Evidence map›Paper›PMID 31273213›Full record

ArticleNature communications2019

Mutations in SMARCB1 and in other Coffin-Siris syndrome genes lead to various brain midline defects.

Alina Filatova, Linda K Rey, Marion B Lechler, Jörg Schaper, Maja Hempel, Renata Posmyk, Krzysztof Szczaluba, Gijs W E Santen, Dagmar Wieczorek, Ulrike A Nuber

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
  17. Article
  18. Rare Hereditary Gynecological Cancer Syndromes.International journal of molecular sciences · 2022
    Review
  19. Genetic testing in individuals with cerebral palsy.Developmental medicine and child neurology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Alina FilatovaStem Cell and Developmental Biology, Technical University Darmstadt, Darmstadt, 64287, Germany.ORCID http://orcid.org/0000-0002-2731-1963
Linda K ReyInstitute of Human Genetics, Medical Faculty, Heinrich Heine University, Düsseldorf, 40225, Germany.
Marion B LechlerStem Cell and Developmental Biology, Technical University Darmstadt, Darmstadt, 64287, Germany.
Jörg SchaperDepartment of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University, Düsseldorf, 40225, Germany.
Maja HempelInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Renata PosmykPodlaskie Medical Centre "GENETICS" Bialystok and Department of Perinatology and Obstetrics, Medical University of Bialystok, Bialystok, 15-276, Poland.
Krzysztof SzczalubaDepartment of Medical Genetics, Medical University Warsaw, Warsaw, 02-106, Poland.
Gijs W E SantenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, 2333 ZA, Netherlands.
Dagmar WieczorekInstitute of Human Genetics, Medical Faculty, Heinrich Heine University, Düsseldorf, 40225, Germany.
Ulrike A NuberStem Cell and Developmental Biology, Technical University Darmstadt, Darmstadt, 64287, Germany. nuber@bio.tu-darmstadt.de.ORCID http://orcid.org/0000-0002-7268-4136
Heinrich Heine University Düsseldorf · DETechnische Universität Darmstadt · DELeiden University Medical Center · NLMedical University of Białystok · PLMedical University of Warsaw · PLUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in genes encoding components of BAF (BRG1/BRM-associated factor) chromatin remodeling complexes cause neurodevelopmental disorders and tumors. The mechanisms leading to the development of these two disease entities alone or in combination remain unclear. We generated mice with a heterozygous nervous system-specific partial loss-of-function mutation in a BAF core component gene, Smarcb1. These Smarcb1 mutant mice show various brain midline abnormalities that are also found in individuals with Coffin-Siris syndrome (CSS) caused by SMARCB1, SMARCE1, and ARID1B mutations and in SMARCB1-related intellectual disability (ID) with choroid plexus hyperplasia (CPH). Analyses of the Smarcb1 mutant animals indicate that one prominent midline abnormality, corpus callosum agenesis, is due to midline glia aberrations. Our results establish a novel role of Smarcb1 in the development of the brain midline and have important clinical implications for BAF complex-related ID/neurodevelopmental disorders.

Indexed as

Abnormalities, MultipleAgenesis of Corpus CallosumAllelesAnimalsChildChild, PreschoolCorpus CallosumDisease Models, AnimalEmbryo, MammalianFaceFemaleHand Deformities, CongenitalHumansInfantIntellectual DisabilityLoss of Function MutationSMARCB1 ProteinSMARCB1 protein, humanSmarcb1 protein, mouse

Identifiers

PMID31273213
PMCPMC6609698
OpenAlexW2954501063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.